150:
383:
187:
464:
409:
218:
469:
314:
180:
414:
248:
319:
590:
378:
347:
309:
258:
112:
Mebazaa A, Kenani N, Denguezli M, et al. (January 2008). "Methotrexate-induced papular eruption following treatment of psoriasis".
585:
534:
484:
173:
99:
59:
149:
494:
329:
263:
268:
489:
253:
524:
393:
514:
560:
539:
211:
71:
48:
529:
504:
499:
243:
519:
479:
204:
509:
324:
419:
227:
291:
555:
362:
474:
357:
52:
424:
352:
129:
95:
27:
157:
121:
278:
339:
579:
436:
301:
286:
44:
235:
32:
431:
441:
133:
196:
125:
384:
Leukotriene receptor antagonist-associated Churg–Strauss syndrome
200:
47:, such as those with rheumatic disease, presenting with
161:
90:
James, William; Berger, Timothy; Elston, Dirk (2005).
548:
457:
450:
402:
371:
338:
300:
277:
234:
92:
26:
21:
58:It has been suggested that it may represent a
212:
181:
8:
465:Acute generalized exanthematous pustulosis
454:
219:
205:
197:
188:
174:
18:
410:Anticonvulsant hypersensitivity syndrome
470:Generalized bullous fixed drug eruption
83:
43:appears in patients being treated with
315:Chemotherapy-induced hyperpigmentation
156:This cutaneous condition article is a
415:Allopurinol hypersensitivity syndrome
389:Methotrexate-induced papular eruption
249:Sulfonamide hypersensitivity syndrome
41:Methotrexate-induced papular eruption
22:Methotrexate-induced papular eruption
7:
320:Scleroderma-like reaction to taxanes
146:
144:
379:Adverse reaction to biologic agents
348:Anticoagulant-induced skin necrosis
310:Chemotherapy-induced acral erythema
259:Adverse effects of fluoroquinolones
160:. You can help Knowledge (XXG) by
94:. (10th ed.). Saunders. Page 181.
14:
535:HIV disease-related drug reaction
485:Drug-related gingival hyperplasia
60:cutaneous small-vessel vasculitis
495:Drug-induced lupus erythematosus
330:Exudative hyponychial dermatitis
148:
490:Drug-induced lichenoid reaction
254:Urticarial erythema multiforme
49:erythematous indurated papules
1:
525:Linear IgA bullous dermatosis
394:Adverse reaction to cytokines
561:Serum sickness-like reaction
540:Photosensitive drug reaction
72:List of cutaneous conditions
269:Jarisch–Herxheimer reaction
607:
591:Connective tissue diseases
530:Toxic epidermal necrolysis
143:
586:Cutaneous condition stubs
505:Drug-induced pigmentation
500:Drug-induced nail changes
51:, usually located on the
515:Stevens–Johnson syndrome
244:Penicillin drug reaction
520:Injection site reaction
480:Drug-induced angioedema
458:Skin and body membranes
510:Drug-induced urticaria
325:Hydroxyurea dermopathy
228:Adverse drug reactions
420:Vaccine adverse event
292:Steroid folliculitis
53:proximal extremities
556:Fixed drug reaction
358:Vitamin K reaction
573:
572:
569:
568:
475:Drug-induced acne
425:Eczema vaccinatum
353:Warfarin necrosis
169:
168:
126:10.1345/aph.1K271
38:
37:
16:Medical condition
598:
455:
363:Texier's disease
264:Red man syndrome
221:
214:
207:
198:
190:
183:
176:
152:
145:
138:
137:
114:Ann Pharmacother
109:
103:
88:
19:
606:
605:
601:
600:
599:
597:
596:
595:
576:
575:
574:
565:
544:
446:
398:
367:
334:
296:
273:
230:
225:
195:
194:
142:
141:
111:
110:
106:
89:
85:
80:
68:
17:
12:
11:
5:
604:
602:
594:
593:
588:
578:
577:
571:
570:
567:
566:
564:
563:
558:
552:
550:
546:
545:
543:
542:
537:
532:
527:
522:
517:
512:
507:
502:
497:
492:
487:
482:
477:
472:
467:
461:
459:
452:
448:
447:
445:
444:
439:
434:
429:
428:
427:
417:
412:
406:
404:
400:
399:
397:
396:
391:
386:
381:
375:
373:
369:
368:
366:
365:
360:
355:
350:
344:
342:
340:Anticoagulants
336:
335:
333:
332:
327:
322:
317:
312:
306:
304:
298:
297:
295:
294:
289:
283:
281:
275:
274:
272:
271:
266:
261:
256:
251:
246:
240:
238:
232:
231:
226:
224:
223:
216:
209:
201:
193:
192:
185:
178:
170:
167:
166:
153:
140:
139:
104:
82:
81:
79:
76:
75:
74:
67:
64:
36:
35:
30:
24:
23:
15:
13:
10:
9:
6:
4:
3:
2:
603:
592:
589:
587:
584:
583:
581:
562:
559:
557:
554:
553:
551:
547:
541:
538:
536:
533:
531:
528:
526:
523:
521:
518:
516:
513:
511:
508:
506:
503:
501:
498:
496:
493:
491:
488:
486:
483:
481:
478:
476:
473:
471:
468:
466:
463:
462:
460:
456:
453:
449:
443:
440:
438:
437:Halogenoderma
435:
433:
430:
426:
423:
422:
421:
418:
416:
413:
411:
408:
407:
405:
401:
395:
392:
390:
387:
385:
382:
380:
377:
376:
374:
370:
364:
361:
359:
356:
354:
351:
349:
346:
345:
343:
341:
337:
331:
328:
326:
323:
321:
318:
316:
313:
311:
308:
307:
305:
303:
299:
293:
290:
288:
285:
284:
282:
280:
276:
270:
267:
265:
262:
260:
257:
255:
252:
250:
247:
245:
242:
241:
239:
237:
233:
229:
222:
217:
215:
210:
208:
203:
202:
199:
191:
186:
184:
179:
177:
172:
171:
165:
163:
159:
154:
151:
147:
135:
131:
127:
123:
120:(1): 138–41.
119:
115:
108:
105:
101:
100:0-7216-2921-0
97:
93:
87:
84:
77:
73:
70:
69:
65:
63:
61:
56:
54:
50:
46:
42:
34:
31:
29:
25:
20:
388:
372:Immunologics
302:Chemotherapy
287:Steroid acne
162:expanding it
155:
117:
113:
107:
91:
86:
57:
45:methotrexate
40:
39:
403:Other drugs
236:Antibiotics
33:Dermatology
580:Categories
432:Bromoderma
78:References
442:Iododerma
28:Specialty
279:Hormones
134:18094347
66:See also
451:General
132:
98:
549:Other
158:stub
130:PMID
96:ISBN
122:doi
582::
128:.
118:42
116:.
62:.
55:.
220:e
213:t
206:v
189:e
182:t
175:v
164:.
136:.
124::
102:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
